Watch for Andexxa, the New Apixaban and Rivaroxaban Reversal Agent
July 2018
You'll hear about Andexxa (an-DEK-sah, inactivated recombinant factor Xa), the new, IV direct oral anticoagulant (DOAC) reversal agent....
Exclusive Subscriber Content
- Best in class medication learning
- Concise recommendations
- Hundreds of practical resources
Login to access this content.
Login